title: Cryptococcal meningitis in non-HIV-infected patients.
abstract: There are few reports on cryptococcal meningitis in non-HIV-infected patients in subtropical areas. We reviewed 94 non-HIV-infected patients microbiologically diagnosed with cryptococcal meningitis and hospitalized at National Taiwan University Hospital, 1977-1996. Forty-two patients (44.7%) had underlying diseases. The main initial manifestations were headache (86.2%), vomiting (72.3%) and fever (69. 1%). The 30 patients with T-cell suppression had more acute illnesses (median duration of symptoms: 14 days vs. 29 days), less typical presentations of meningitis, and reduced inflammatory responses compared with the 64 without T cell suppression. There was no statistical difference between patients who received amphotericin B treatment for 10 weeks and those received amphotericin B with subsequent fluconazole treatment, in terms of mortality rate and recurrence rate. Seventy-five patients (79.8%) had satisfactory clinical responses, and two relapsed. Eighteen patients died (19.1%) and 10 of these died within 2 weeks of hospitalization. Patients in this series had outcomes comparable with those from temperate and even tropical countries with high percentages of immunocompetent hosts. Factors significantly associated with death were lymphoma, semicoma, leukocytosis, and initial high titres of cryptococcal antigen in cerebral spinal fluid (especially >/=1 : 512). On multivariate analysis, lymphoma and initial high cryptococcal antigen titres were independent predictors of mortality.
authors.affiliation: Departments of Internal Medicine and. Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
authors.forename: C C
authors.initials: CC
authors.lastname: Shih
authors.forename: Y C
authors.initials: YC
authors.lastname: Chen
authors.forename: S C
authors.initials: SC
authors.lastname: Chang
authors.forename: K T
authors.initials: KT
authors.lastname: Luh
authors.forename: W C
authors.initials: WC
authors.lastname: Hsieh
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D000293:Adolescent; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D005334:Fever / Q000209:etiology; D015725:Fluconazole / Q000627:therapeutic use; D006261:Headache / Q000209:etiology; D006801:Humans; D008297:Male; D016919:Meningitis, Cryptococcal / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D008875:Middle Aged; D012008:Recurrence; D015996:Survival Rate; D013601:T-Lymphocytes / Q000276:immunology; D013624:Taiwan / Q000453:epidemiology; D014839:Vomiting / Q000209:etiology
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole